<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr14-2050312120973499">
 <label>14</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Khoury</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Rajamanickam</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Grossberg</surname>
    <given-names>GT.</given-names>
   </name>
  </person-group>
  <article-title>An update on the safety of current therapies for Alzheimer’s disease: focus on rivastigmine</article-title>. 
  <source>Ther Adv Drug Saf</source>
  <year>2018</year>; 
  <volume>9</volume>(
  <issue>3</issue>): 
  <fpage>171</fpage>–
  <lpage>178</lpage>.
  <pub-id pub-id-type="pmid">29492246</pub-id>
 </mixed-citation>
</ref>
